Hosprtal, Oxford, I % nitrogen cDntaining metabolites, the amino acid (AA) metabolism and its alterations during carnitine (C) therapy have not been studied. Ten VPA treated C deficient children equimolar C were given over a 14 days period. Before C treatment the fasting plasma levels of ammonia, taurine, aspartate, hydroxyproline, glutamate, proline, glycue, alanine, methionine were elevated, the levels of leucine and ornithine were depressed in VPA treated children as compared to controls (p<o.o5), their levels remained unchanged after C therapy. The elevated ammonia and glutamate with normal glutemine levels show impaired glutamate-glutamine cycle. After a standard meal the plasma levels of AA exhibited different elevation before and after C treatment. The urinary output of AA mas lower in the VPA treated group, output of 8 individual AA increased after the C treatment. showinn that the C mnv influence -. -. . . -the AA metabolism, iet rnostvchanees are C independent and are caused probably by the VPA per se. CND is.a rare disorder characterized by severe unconjugated hyperbilirubinemia appearing in the first days of life and persisting throughout life. We tried to control the hyperbilirubinemia in an infant with CND by parenteral administration of Sn-Pp, a strong inhibitor of heme-oxygenase. The dose administered was 0.5 ui\lol/kg b.w. Mild transient erythema appeared when the infant was exposed to sunlight after injection, but not during phototherapy. The serum clearance of Sn-Pp was found to be biphasic: over 90% of the Sn-Pp present in the serum 5 h after injection is eliminated within 48 h; the remaining Sn-Pp undergoes very slov~ clearance which is virtually complete after 7 days. Different treatment schedules have been tried; however, in no case was it possible to discontinue phototherapy. A suitable combination of phototherapy and Sn-Pp administration apepars to yield the most promising results. In particular, it is possible to maintain the serum bilirubin concentration below 14-15 mg/dl combining one injection of Sn-Pp every 7-10 days with 5 hrs of phototherapy per night.
CND is.a rare disorder characterized by severe unconjugated hyperbilirubinemia appearing in the first days of life and persisting throughout life. We tried to control the hyperbilirubinemia in an infant with CND by parenteral administration of Sn-Pp, a strong inhibitor of heme-oxygenase. The dose administered was 0.5 ui\lol/kg b.w. Mild transient erythema appeared when the infant was exposed to sunlight after injection, but not during phototherapy. The serum clearance of Sn-Pp was found to be biphasic: over 90% of the Sn-Pp present in the serum 5 h after injection is eliminated within 48 h; the remaining Sn-Pp undergoes very slov~ clearance which is virtually complete after 7 days. Different treatment schedules have been tried; however, in no case was it possible to discontinue phototherapy. A suitable combination of phototherapy and Sn-Pp administration apepars to yield the most promising results. In particular, it is possible to maintain the serum bilirubin concentration below 14-15 mg/dl combining one injection of Sn-Pp every 7-10 days with 5 hrs of phototherapy per night.
Ninety-one newborn babies had a continuous record of the electroence halogram (EEG) while receivin intensive care. Seizures occured in PO% and after parental consent 48 entered a randomised trial of 4 anticonvulsants. The loading doses were: phenobarbitone 2Orngs/kg, phenytoin 30mgs/kg, clonazeparn 0.25m s, sodium valproate lOrngs/kg. A pol raphic record of physiological !aria%les was made during the infusion anifor the next 24 hours. The continuous EEG was ma~nta~ned for 5 days after treatment. The roups were similar for birthwei ht and estational a e Frequency and ckratlon of seizure was decrease{ by all h g s but paenvtoin was the most effective. The median time to control selzures ranged from 18.8 hr (phen toin) to 120 hr (phenobarbitone and clonazepam). Heart rate. hood pressure and intracr~nial ressure varied widely after all 4 drugs. Cardiac Pepreuion was anlcularry noticed in asphyxiated babies w~th myocard~al ischaem~a. &ese data suggest that the gotentially adverse effects of high doses of mti-convulsants must be alanced against the benefits ot early effective control.
OPIATE INFUSIONS FOR PRETERM CHILDREN?
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Department of Child Health Liverpool Maternity Hospital, Liverpool. Despite r e c e n t c a l l s f o r the administration of o p i a t e s t o v e n t i l a t e d neswborn i n f a n t s , t h e r e is a paucity of d a t a t o support t h e i r use. Single dose s t u d i e s during surgery suggest t h a t commonly used drugs have a marked reduction i n clearance.
This study e v a l u a k t h e use of a s h o r t a c t i n g s y n t h e t i c opiod, a l f e n t a n i l .
22 v e n t i l a t e d , paralysed preterm i n f a n t s with hyaline membrane d i s e a s e (median BW:1348g (r:690-4084g); median GA:30 weeks ( r : 2 5 -3 6~) ) were given 20 micrograms/Kg a l f e n t a n i l by slow intravenous i n j e c t i o n over two minutes. Peak serum concentration (med(r)) was 67ng/ml (13-606). clearance O.Sml/rnin/kg (0.6-9.62) and elimination h a l f l i f e 321 mins (64-1251). Transient depression of BP and h e a r t r a t e was noted. Using t h e s e d a t a i n s i x c h i l d r e n s a t i s f a c t o r y serum l e v e l s of a l f e n t a n i l were achieved using 20 micrograms/Kg over 30 mins followed by 5micrograms/Kg/hour with no c a r d i o r e s p i r a t o r y e f f e c t s . Recent animal experiments demonstrated t h a t the c o n t r a c t i l i t y of the inmature myocardrum 1s supported l a r e l y by the rnflux of r a l r i t : n a c r o q e the e a r c o l e m and onlv wEen mvocardiun matures ~? .~~~~l~~~~~~~a l f i~~u~t a k e a n d relehse bv the sarcoolasmic ----reticulum olavs an incrbasinnlv imoortant ?ole i n the-developnent of mybcai-dial c o n t r a c t i I i t y . The purpose of t h i s study was therefore t o d e l i n e a t e the acute hemodynamic e f f e c t s of parent e r a l calcrum treatment r n c r r t i c a l l y r l l and hypocalcemlc premature and mature newborns. Methods: The hemodvnamicallv unstable and hvoocalciemic newborns C a r ? < 1 . 0 m o l / l j receivea a calcium chloride (CaCl . 2 ) infusion 14mg/kg of elemental Cat+) over a period of two min. Results: After administration of CaCl2 ~t r o k e volcne (SV), cardl a c outout (CO. oulse conture technioue) and blood oressure (BP) --. i n c r e a s~d s i e n i f ; c a n t l v . whereas h e a i t r a t e (HR) reibined uni chan ed and zystemic vHscular resistance decreased. The changes of d e s e parameters a r e d i s t i n c t l y pronounced i n the immature newborns and seem t o be inversely proportional t o the i n i t i a l Ca+f-level. Conclusions: Intravenous administration of calcium t o hernodynam; i c a l l v unstable and hvoocalcemic newborns leads t o an Increase r n BP s~I and CO. Since fik i s nearly unchanged t h i s means an energ e i i c a l l y favorable improvement of myocardial function. The pronounced rncrease of SV CO and BP i n the immature newborn and the dependency of these ch;nges on the i n i t i a l s e r a c a l c i~. l evel are i n agreenent wrth the above mentioned anlmal experrments. Universit?itskinderklinik, Langenbeckstr. 1. D-6500 Mainz. FBG.
